AstraZeneca's silence on CEO helps wipe out 3 billion pounds

LONDON (Reuters) - Uncertainty over the future of AstraZeneca Chief Executive Pascal Soriot drove the Anglo-Swedish drugmaker's shares lower again on Friday, taking the cost of two days of silence to more than 3 billion pounds ($3.9 billion).

AstraZeneca's silence on CEO helps wipe out 3 billion pounds
Read More


Bagikan Berita Ini